The Commissioner of Taxation is pursuing a former Big Four partner for allegedly promoting tax exploitation schemes for clients. But a fight has broken out in court over whether his identity — and the name of the accounting firm — should be suppressed.
A judge has found that ANZ breached continuous disclosure rules by failing to disclose a $750 million bailout by underwriters Deutsche Bank, Citigroup and JP Morgan during its $2.5 billion equity capital raising in August 2015.
The Australian Securities and Investments Commission is seeking to restrain payday lenders Cigno and BSF Solutions from enforcing loan fees against 10,000 customers.
The ACCC has approved the buyout of Australian energy giant Origin Energy, after finding that significant competition concerns were outweighed by the likely benefits to the country’s transition to renewable energy.
The former CEO of collapsed Sydney stockbroking firm BBY Limited has been charged with two counts of aiding, abetting, counselling or procuring fraud.
A retired law firm partner has taken his battle with the ATO to the High Court, arguing he is not liable to be taxed on $182,000 in goodwill payments he received on exiting the firm’s partnership in 2008.
The ASX-listed Shine Lawyers has earned marks for improvement in a review by ASIC of its disclosures relating to interest on litigation funding loans, the corporate regulator said Thursday.
Finder Wallet has argued it did not need a financial services licence to sell its crypto product Finder Earn because it was not money, but instead allowed customers to purchase an asset and acted as a marketing tool to funnel users to its app.
The corporate regulator has again initiated proceedings against Gold Coast-based BHF Solutions and Cigno for allegedly providing credit without a licence after the lenders failed to convince the Full Court that their services fell outside the scope of the Credit Act.
Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.